Learn More
Medchemexpress LLC Gefitinib hydrochloride | 184475-55-6 | MFCD00952718 | 99.8% | C22H25Cl2FN4O3 | 1 G

Supplier: Medchemexpress LLC HY50895A1G
Gefitinib hydrochloride is a potent, selective, and orally active EGFR tyrosine kinase inhibitor, intended for research use only. It selectively inhibits EGF-stimulated tumor cell growth and blocks EGFR autophosphorylation in tumor cells. It also induces autophagy and exhibits antitumour activity.
- Potent and selective EGFR tyrosine kinase inhibitor.
- IC50 of 33 nM against EGFR.
- Selectively inhibits EGF-stimulated tumor cell growth with an IC50 of 54 nM.
- Blocks EGF-stimulated EGFR autophosphorylation in tumor cells.
- Induces autophagy.
- Exhibits antitumour activity.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.